Bone Biologics closes $5.1M public offering of 3.78M units at $1.35/unit

Bone Biologics Corp

Gross proceeds of $5.1M from offering of 3,777,778 units at $1.35 per unit.
Each unit includes one common share and three Series A, B, C warrants exercisable at $1.62, $1.35, $2.16 respectively.
Warrants expire five years from issuance; Series C warrants eligible for cashless exercise upon $10M volume trigger.
Net proceeds to fund clinical trials, patent portfolio, CRO retention, and working capital.
WallachBeth Capital acted as sole book-runner; over-allotment option partially exercised for 556,037 warrants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.